AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 182 min read$LIFE

Capozzi Christopher M. sold $894K of LIFE

Capozzi Christopher M. (Chief Financial Officer) sold 26,184 shares of Ethos Technologies Inc. (LIFE) at an average of $34.14 ($33.92–$34.44, $0.89M total) across 2 trades on 2026-08-17.

Original reporting
SEC EDGAR · Capozzi Christopher M.
Published Aug 18, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 10:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$LIFE
Neutral
medium confidence
Mentioned
$LIFE
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFENeutralLow
01

Why it matters

The disclosed open-market sale reduces the insider’s direct holdings from 639,044 shares after the trades, but the filing contains no accompanying guidance, earnings, or business update.

02

Market read

Traders may note the insider sale for sentiment, but there is no new fundamental information to drive a durable repricing.

03

What to watch

The article does not state total insider holdings, prior sale history, or whether other insiders sold/bought around the same time, limiting inference from a single transaction.

Relevance 5/10Novelty 3/10Timing: filed after-hours on 2026-08-18, covering sales executed 2026-08-17

Background

The article is an SEC Form 4 insider transaction disclosure for Ethos Technologies Inc. (LIFE) by its CFO.

Company-level read

Ticker impact

$LIFENeutralMedium confidence
Context

Ethos Technologies CFO Christopher Capozzi sold about $893.9K of LIFE shares in two open-market trades on 2026-08-17.

Expected impact

Low likelihood of sustained price impact; any reaction is likely limited to short-term sentiment.

Evidence & confidence

The filing is a Form 4 insider sale, but the article provides no new company-specific operational, financial, or regulatory development.

Market effects

Sector

Minimal, as this is company-specific insider activity with no sector-wide signal provided.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs; the absence of a stated 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • issuer
    LIFE

    Ethos Technologies Inc., the company whose CFO reported an open-market sale of shares via SEC Form 4.

  • insider
    Christopher M. Capozzi

    Chief Financial Officer of Ethos Technologies Inc., reported selling 26,184 shares on 2026-08-17.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

LIFE insider trading history →

Related articles

SEP 3
$LIFEMed

Ethos (LIFE) Grows Revenue 113% While Margins Quietly Compress

Ethos Technologies (LIFE) reported Q2 revenue growth of 113% to $189.6M, with new policies up 133%. Gross profit margin was 98%, but net income rose only 5% to $19.5M. The company authorized a $100M stock buyback. Q3 revenue guidance is $160M-$164M, and full-year guidance is $727M-$731M. Margins compressed, with GAAP net loss of $146.9M for H1 2026 due to stock-based compensation.

insidermonkey.com3 min
AUG 11
$LIFEMedAI 9/10

Ethos (LIFE) Q2 2026 Earnings Call Transcript

Ethos Technologies (LIFE) reported Q2 2026 revenue of $189.6 million, up 113% Y/Y, with direct revenue $116.5 million (+131%) and third-party revenue $73.1 million (+90%). Adjusted EBITDA was $35.2 million (19% margin). Net income was $19.5 million. Full-year 2026 guidance: revenue $727-$731 million and adjusted EBITDA $119-$123 million. Up to $100 million Class A repurchase authorized.

fool.com7 min
AUG 5
$LIFEMed

Top SMid Cap Pick: Ethos Technologies Leads Citi’s Rankings

Citi analyst Ronald Josey named Ethos Technologies (LIFE) his top SMID-cap pick after the company’s Q2 results. Activated policies growth accelerated to 133% YoY, with 107,800 net activated policies. Revenue rose to $189.6M (+113% YoY). Ethos raised 2026 revenue guidance to $727M-$731M and adjusted EBITDA to $119M-$123M. Citi lifted its price target to $33 and kept Buy/High Risk.

investing.com4 min
AUG 3
$LIFEHigh

Ethos Technologies Inc. (LIFE): Results of Operations and Financial Condition

Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ethos Reports Second Quarter Fiscal Year 2026 Financial Results • Q2 Revenue grew 113% year-over-year to $190 million • Q2 Direct Channel Revenue grew 131% year-over-year to $116 million • Q2 Third-Party Revenue grew 90% year-over-year to $73 million • Board of Direc

SEC EDGAR 8-K4 min